for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Iqvia Holdings Inc

IQV.N

Latest Trade

157.12USD

Change

-3.38(-2.11%)

Volume

2,368,797

Today's Range

156.76

 - 

160.70

52 Week Range

81.84

 - 

170.47

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
160.50
Open
160.38
Volume
2,368,797
3M AVG Volume
21.81
Today's High
160.70
Today's Low
156.76
52 Week High
170.47
52 Week Low
81.84
Shares Out (MIL)
191.27
Market Cap (MIL)
30,052.49
Forward P/E
25.45
Dividend (Yield %)
--

Next Event

Q3 2020 IQVIA Holdings Inc Earnings Release

Latest Developments

More

IQVIA Holdings Reports Q2 Adjusted Earnings Per Share $1.18

IQVIA Appoints Ron Bruehlman Executive Vice President And Interim CFO

Iqvia Announces Pricing Of Offering Of Senior Notes

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Iqvia Holdings Inc

IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.

Industry

Biotechnology & Drugs

Contact Info

4820 Emperor Blvd

DURHAM, NC

27703-8426

United States

+1.919.9982000

https://ir.iqvia.com/

Executive Leadership

Ari Bousbib

Chairman of the Board, President, Chief Executive Officer

Ronald E. Bruehlman

Interim Chief Financial Officer, Executive Vice President

Kevin C. Knightly

President - Information and Technology Solutions

Walter Richard Staub

President - Research and Development Solutions

Eric M. Sherbet

Executive Vice President, General Counsel, Secretary

Key Stats

1.77 mean rating - 22 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

8.1K

2018

10.4K

2019

11.1K

2020(E)

11.0K
EPS (USD)

2017

4.670

2018

5.550

2019

6.390

2020(E)

6.173
Price To Earnings (TTM)
235.89
Price To Sales (TTM)
2.75
Price To Book (MRQ)
5.38
Price To Cash Flow (TTM)
21.47
Total Debt To Equity (MRQ)
218.69
LT Debt To Equity (MRQ)
216.15
Return on Investment (TTM)
0.85
Return on Equity (TTM)
0.70

Latest News

Latest News

Biogen names IQVIA's Michael McDonnell CFO

Biogen Inc on Tuesday named IQVIA Holding Inc's Michael McDonnell as chief financial officer, effective Aug. 15.

BRIEF-IQVIA Collaborates With LMC Manna Research To Launch Clinical Investigation Site In Canada

* IQVIA COLLABORATES WITH LMC MANNA RESEARCH TO LAUNCH CLINICAL INVESTIGATION SITE IN CANADA Source text for Eikon: Further company coverage:

BRIEF-Iqvia Announces Pricing Of Offering Of Senior Notes

* IQVIA HOLDINGS INC - PRICED EUR 711 MILLION SENIOR NOTES DUE 2028

BRIEF-Iqvia Unit To Raise $800 Mln Equivalent Through An Offering Of Euro-Denominated Senior Notes Due 2028

* IQVIA HOLDINGS INC - UNIT INTENDS TO RAISE $800 MILLION EQUIVALENT IN GROSS PROCEEDS THROUGH AN OFFERING OF EURO-DENOMINATED SENIOR NOTES DUE 2028

BRIEF-IQVIA Launches HCP/O Engagement Management

* IQVIA HOLDINGS INC - LAUNCHES HCP/O ENGAGEMENT MANAGEMENT, TO ADDRESS BUSINESS AND COMPLIANCE NEEDS OF HEALTHCARE PROFESSIONALS Source text for Eikon: Further company coverage:

BRIEF-Iqvia Reports Q1 Adjusted Earnings Per Share Of $1.50

* IQVIA REPORTS FIRST-QUARTER 2020 RESULTS; ISSUES SECOND-QUARTER 2020 GUIDANCE AND UPDATES FULL-YEAR 2020 GUIDANCE

BRIEF-Iqvia Holdings Launches First Technology-Enabled Covid-19 Trial Matching Solution Within U.S.

* IQVIA HOLDINGS INC - LAUNCHES FIRST TECHNOLOGY-ENABLED COVID-19 TRIAL MATCHING SOLUTION WITHIN U.S. TO ACCELERATE TREATMENT AND VACCINE DEVELOPMENT Source text for Eikon: Further company coverage:

BRIEF-IQVIA Provides Revised First-Quarter 2020 Guidance

* IQVIA PROVIDES UPDATE ON BUSINESS CONDITIONS IN LIGHT OF COVID-19 AND PROVIDES REVISED FIRST-QUARTER 2020 GUIDANCE; IQVIA WILL ANNOUNCE FIRST-QUARTER RESULTS AND UPDATE FULL-YEAR 2020 GUIDANCE ON APRIL 28, 2020

BRIEF-IQVIA Inc Borrows $900 Mln In Additional Term Loans - SEC Filing

* IQVIA HOLDINGS INC - UNIT BORROWED $900 MILLION IN ADDITIONAL TERM LOANS - SEC FILING Source : (http://bit.ly/3cPxcoD) Further company coverage:

BRIEF-IQVIA Holdings Inc Says CEO Ari Bousbib's 2019 Total Compensation Was $22.1 Million Versus $16.5 Million In 2018

* IQVIA HOLDINGS INC SAYS CEO ARI BOUSBIB'S 2019 TOTAL COMPENSATION WAS $22.1 MILLION VERSUS $16.5 MILLION IN 2018 – SEC FILING

BRIEF-IQVIA Announces Repurchase Of Common Stock

* IQVIA HOLDINGS INC - HAS AGREED TO PURCHASE AGGREGATE OF 1 MILLION SHARES OF COMMON STOCK IN PRIVATE TRANSACTION FROM CERTAIN OF ITS EXISTING STOCKHOLDERS

BRIEF-Iqvia Reports Q4 Earnings Per Share $0.09

* IQVIA REPORTS FOURTH-QUARTER AND FULL-YEAR 2019 RESULTSISSUES FIRST-QUARTER AND FULL-YEAR 2020 GUIDANCE

BRIEF-Iqvia Holdings Q1 GAAP Earnings Per Share $0.32

* IQVIA REPORTS FIRST-QUARTER 2018 RESULTS AND RAISES FULL-YEAR 2018 REVENUE GUIDANCE

BRIEF-Iqvia Sees Q1 2018 Adjusted Earnings Per Share $1.23 To $1.30

* IQVIA REPORTS FOURTH-QUARTER AND FULL-YEAR 2017 RESULTS, ISSUES FIRST-QUARTER AND FULL-YEAR 2018 GUIDANCE

BRIEF-IQVIA Announces Pricing Of Secondary Public Offering

* IQVIA HOLDINGS INC - PRICING OF UNDERWRITTEN, SECONDARY PUBLIC OFFERING OF 10 MILLION SHARES OF ITS COMMON STOCK BY CERTAIN OF ITS EXISTING STOCKHOLDERS

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up